Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge

(MedPage Today) -- An FDA advisory committee on Wednesday voted 17-4 (with one abstention) to recommend removing a "lockout period" from a risk evaluation and mitigation strategy (REMS) for isotretinoin prescribing that requires patients to wait...

Source: MedPage Today OB/GYN - March 29, 2023 Category: OBGYN Source Type: news